DE60313474D1 - Behandlung von dyskinesie - Google Patents

Behandlung von dyskinesie

Info

Publication number
DE60313474D1
DE60313474D1 DE60313474T DE60313474T DE60313474D1 DE 60313474 D1 DE60313474 D1 DE 60313474D1 DE 60313474 T DE60313474 T DE 60313474T DE 60313474 T DE60313474 T DE 60313474T DE 60313474 D1 DE60313474 D1 DE 60313474D1
Authority
DE
Germany
Prior art keywords
dyskinesia
treatment
topiramate
parkinsonism
dopa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60313474T
Other languages
English (en)
Other versions
DE60313474T2 (de
Inventor
Alan Crossman
Michael Hill
Montague Silverdale
Jonathan Brotchie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Motac Neuroscience Ltd
Original Assignee
Motac Neuroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0307824A external-priority patent/GB0307824D0/en
Application filed by Motac Neuroscience Ltd filed Critical Motac Neuroscience Ltd
Publication of DE60313474D1 publication Critical patent/DE60313474D1/de
Application granted granted Critical
Publication of DE60313474T2 publication Critical patent/DE60313474T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Resistance Heating (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60313474T 2002-09-17 2003-09-01 Behandlung von dyskinesie Expired - Lifetime DE60313474T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41159702P 2002-09-17 2002-09-17
US411597P 2002-09-17
GB0307824A GB0307824D0 (en) 2003-04-04 2003-04-04 Treatment of dyskinesia
GB0307824 2003-04-04
PCT/GB2003/003801 WO2004026299A1 (en) 2002-09-17 2003-09-01 Treatment of dyskinesia

Publications (2)

Publication Number Publication Date
DE60313474D1 true DE60313474D1 (de) 2007-06-06
DE60313474T2 DE60313474T2 (de) 2008-01-03

Family

ID=32031898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60313474T Expired - Lifetime DE60313474T2 (de) 2002-09-17 2003-09-01 Behandlung von dyskinesie

Country Status (13)

Country Link
US (1) US20060069039A1 (de)
EP (1) EP1539135B1 (de)
JP (1) JP2006502234A (de)
CN (1) CN100502856C (de)
AT (1) ATE360415T1 (de)
AU (1) AU2003267557B2 (de)
CA (1) CA2499200A1 (de)
CY (1) CY1106759T1 (de)
DE (1) DE60313474T2 (de)
DK (1) DK1539135T3 (de)
ES (1) ES2286453T3 (de)
PT (1) PT1539135E (de)
WO (1) WO2004026299A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924941D0 (en) * 1999-10-22 1999-12-22 Univ Manchester Treatment of dyskinesia
GB0027020D0 (en) * 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US20070179161A1 (en) * 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
CN102548555A (zh) * 2009-07-31 2012-07-04 克莱拉有限公司 用于治疗帕金森病的组合物和方法
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN107660147B (zh) * 2015-05-26 2021-04-30 抗菌技术生物技术研究与发展股份有限公司 用于治疗帕金森病和相关障碍的组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
DE19604920A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
NZ514813A (en) * 1999-04-08 2004-12-24 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
US6420369B1 (en) * 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
NZ548578A (en) * 2001-02-02 2008-03-28 Ortho Mcneil Pharm Inc Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
JP2006502234A (ja) 2006-01-19
ATE360415T1 (de) 2007-05-15
PT1539135E (pt) 2007-07-12
EP1539135B1 (de) 2007-04-25
DK1539135T3 (da) 2007-09-17
CA2499200A1 (en) 2004-04-01
CY1106759T1 (el) 2012-05-23
EP1539135A1 (de) 2005-06-15
WO2004026299A1 (en) 2004-04-01
AU2003267557B2 (en) 2009-02-26
US20060069039A1 (en) 2006-03-30
DE60313474T2 (de) 2008-01-03
AU2003267557A1 (en) 2004-04-08
CN1681491A (zh) 2005-10-12
CN100502856C (zh) 2009-06-24
ES2286453T3 (es) 2007-12-01

Similar Documents

Publication Publication Date Title
ATE368031T1 (de) Neue gamma secretase inhibitoren
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
DE60124085D1 (de) Pde-v hemmer zur behandlung von morbus parkinson
IS8058A (is) Sýklísk súlfónamíð til að hamla gamma seytiasa
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
ATE536349T1 (de) In der 2-stellung durch phenyl substituierte 1h- benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
ATE461923T1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
DE60026155D1 (de) Einige alkylendiamin-substituierte heterocyclen
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
RS52780B (en) MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS
EA200802213A1 (ru) Способы лечения заболеваний крови
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
ATE484508T1 (de) Furylverbindungen
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE60313474D1 (de) Behandlung von dyskinesie
ATE474571T1 (de) Behandlung von melanoma mittels p- aminobenzoesäure (paba)
DE602004026597D1 (de) Behandlung von alzheimer-krankheit und verwandten zuständen
EA200971003A1 (ru) Бициклическое соединение и его фармацевтическое применение
ATE519740T1 (de) Tetrahydroindolderivate zur behandlung von alzheimer-krankheit
ATE346040T1 (de) Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit
ATE423102T1 (de) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
DE60105028D1 (de) Ruthenium (ii) verbindungen in der krebsbehandlung
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition